FULC

Fulcrum Therapeutics (FULC)

Fulcrum Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FULC

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/19	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/06/19	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/06/19	05:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/06/18	05:37	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/05/13	20:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/05/13	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/05/10	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/03/09	08:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/03/09	08:00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/03/06	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/28	07:18	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/28	07:12	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/28	06:01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/02/27	21:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/01/31	11:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2024/01/31	11:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/11/07	21:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/11/07	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/10/03	05:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/22	20:48	Dow Jones News	Fulcrum Therapeutics Shares Rally Premarket as FDA Lifts Study Hold	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/22	20:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/12	05:53	GlobeNewswire Inc.	Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/03	20:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/08/03	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/07/11	06:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/07/08	06:30	GlobeNewswire Inc.	Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/07/04	05:16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/06/30	05:24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/06/30	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FULC	Fulcrum Therapeutics Inc
2023/06/30	05:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:FULC	Fulcrum Therapeutics Inc